{
    "ticker": "TFPM",
    "name": "TFF Pharmaceuticals, Inc.",
    "description": "TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative drug delivery solutions utilizing its proprietary Thin Film Freezing (TFF) technology. Founded in 2018, TFF Pharmaceuticals aims to enhance the delivery of existing drugs and to create new therapeutic options for patients with respiratory diseases and other medical conditions. The company's TFF technology allows for the transformation of liquid pharmaceuticals into dry powder formulations, enabling easier inhalation and administration. This method has the potential to improve the bioavailability and efficacy of various drugs. TFF Pharmaceuticals is currently advancing several product candidates through clinical trials, including those targeting serious respiratory diseases. The company is committed to improving patient outcomes through advanced drug delivery systems and strives to collaborate with pharmaceutical partners to bring its innovative solutions to market. With a seasoned management team and a strong focus on research and development, TFF Pharmaceuticals is positioned to make significant contributions to the biopharmaceutical industry.",
    "industry": [
        "Biopharmaceuticals",
        "Drug Delivery"
    ],
    "headquarters": "Austin, Texas, USA",
    "founded": "2018",
    "website": "https://www.tffpharma.com",
    "ceo": "Glenn Mattes",
    "social_media": {
        "twitter": "https://twitter.com/TFFPharma",
        "linkedin": "https://www.linkedin.com/company/tff-pharmaceuticals/"
    },
    "investor_relations": "https://www.tffpharma.com/investors",
    "key_executives": [
        {
            "name": "Glenn Mattes",
            "position": "CEO"
        },
        {
            "name": "Kathy H. Hsu",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Respiratory Treatments",
            "products": [
                "TFF Vaping Products",
                "TFF Pulmonary Products"
            ]
        }
    ],
    "seo": {
        "meta_title": "TFF Pharmaceuticals, Inc. | Innovative Drug Delivery Solutions",
        "meta_description": "Learn about TFF Pharmaceuticals, Inc., a leader in transforming drug delivery through Thin Film Freezing technology. Discover our commitment to respiratory treatments.",
        "keywords": [
            "TFF Pharmaceuticals",
            "Thin Film Freezing",
            "Biopharmaceuticals",
            "Drug Delivery",
            "Respiratory Treatments"
        ]
    },
    "faq": [
        {
            "question": "What is TFF Pharmaceuticals known for?",
            "answer": "TFF Pharmaceuticals is known for its innovative drug delivery solutions utilizing Thin Film Freezing technology."
        },
        {
            "question": "Who is the CEO of TFF Pharmaceuticals?",
            "answer": "Glenn Mattes is the CEO of TFF Pharmaceuticals, Inc."
        },
        {
            "question": "Where is TFF Pharmaceuticals headquartered?",
            "answer": "TFF Pharmaceuticals is headquartered in Austin, Texas, USA."
        },
        {
            "question": "What are TFF Pharmaceuticals' main products?",
            "answer": "TFF Pharmaceuticals' main products include innovative formulations for respiratory treatments."
        },
        {
            "question": "When was TFF Pharmaceuticals founded?",
            "answer": "TFF Pharmaceuticals was founded in 2018."
        }
    ],
    "competitors": [
        "INFI",
        "AXGT",
        "HGEN"
    ],
    "related_stocks": [
        "MRNA",
        "PFE",
        "JNJ",
        "AMGN"
    ]
}